Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Ryan Sullivan currently holds 40,773 shares of Avalo Therapeutics, Inc. (AVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Ryan Sullivan has been a net buyer of AVTX stock. They have purchased $21.6K and sold $0 worth of shares.
Christopher Ryan Sullivan's most recent insider trade was on Jun 10, 2026, when they sold 138 shares at $13.10 per share.
Christopher Ryan Sullivan serves as Executive at Avalo Therapeutics, Inc. (AVTX). They have executed 8 insider transactions totaling $21.6K over their tenure at the company.
Christopher Ryan Sullivan holds the position of Executive at Avalo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Christopher Ryan Sullivan has shown a buying trading pattern, with $21.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher Ryan Sullivan was on Dec 10, 2020, when they purchased $11.6K worth of CERC shares. This transaction involved 5,095 shares at $2.28 per share.
Christopher Ryan Sullivan currently owns 40,773 shares of Avalo Therapeutics, Inc. (AVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Ryan Sullivan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Ryan Sullivan has 8 Form 4 filings on record as an insider at Avalo Therapeutics, Inc..
Set alerts for Christopher Ryan Sullivan and 40,000+ other insiders.